Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Stomach Ulcer D013276 75 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Otitis Media D010033 12 associated lipids
Carcinoma, Basal Cell D002280 6 associated lipids
Bacterial Infections D001424 21 associated lipids
Pain D010146 64 associated lipids
Stomach Diseases D013272 7 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Lung Diseases D008171 37 associated lipids
Sarcoidosis D012507 13 associated lipids
Hyperglycemia D006943 21 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Skin Neoplasms D012878 12 associated lipids
Burns D002056 34 associated lipids
Inflammation D007249 119 associated lipids
Colitis D003092 69 associated lipids
Per page 10 20 50 100 | Total 276

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
Graybill JR and Bocanegra R Treatment alternatives for Mycobacterium kansasii. 2001 J. Antimicrob. Chemother. pmid:11266413
Ferwerda A et al. Efficacy, safety and tolerability of 3 day azithromycin versus 10 day co-amoxiclav in the treatment of children with acute lower respiratory tract infections. 2001 J. Antimicrob. Chemother. pmid:11266417
Butler T et al. In vitro effects of azithromycin on Salmonella typhi: early inhibition by concentrations less than the MIC and reduction of MIC by alkaline pH and small inocula. 2001 J. Antimicrob. Chemother. pmid:11266420
Kawamura-Sato K et al. Postantibiotic suppression effect of macrolides on the expression of flagellin in Pseudomonas aeruginosa and Proteus mirabilis. 2001 J. Infect. Chemother. pmid:11406758
St Clair EW et al. The effects of intravenous doxycycline therapy for rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. 2001 Arthritis Rheum. pmid:11357896
Kaplan EL et al. Macrolide therapy of group A streptococcal pharyngitis: 10 days of macrolide therapy (clarithromycin) is more effective in streptococcal eradication than 5 days (azithromycin). 2001 Clin. Infect. Dis. pmid:11360224
Nilius AM et al. Comparative in vitro activity of ABT-773, a novel antibacterial ketolide. 2001 Antimicrob. Agents Chemother. pmid:11408246
Vallejo C et al. Resolution of cyclosporine-induced gingival hyperplasia resistant to azithromycin by switching to tacrolimus. 2001 Haematologica pmid:11146586
Schlegel L et al. In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995-1999. 2001 Clin. Microbiol. Infect. pmid:11531981
Kain KC et al. Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens. 2001 Clin. Infect. Dis. pmid:11418883
Tabbara KF Trachoma: a review. 2001 J Chemother pmid:11434524
Lisby G et al. Bacteremia and meningitis caused by a macrolide-sensitive strain of Streptococcus pneumoniae during treatment with azithromycin. 2001 Clin. Infect. Dis. pmid:11438918
Ishimatsu Y et al. [Effect of macrolide antibiotics on apoptosis induction]. 2001 Jpn J Antibiot pmid:11439895
O'Farrell N Donovanosis: an update. 2001 Int J STD AIDS pmid:11394976
Schmutz JL et al. [Skin eruptions due to azithromycin (Azadose-Zithromax) and infectious mononucleosis]. 2001 Ann Dermatol Venereol pmid:11395665
Amsden G et al. Lack of an effect of azithromycin on the disposition of zidovudine and dideoxyinosine in HIV-infected patients. 2001 J Clin Pharmacol pmid:11210404
Tyteca D et al. Azithromycin, a lysosomotropic antibiotic, impairs fluid-phase pinocytosis in cultured fibroblasts. 2001 Eur. J. Cell Biol. pmid:11499789
Sahm DF et al. Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis. 2001 Antimicrob. Agents Chemother. pmid:11257013
Lietman T and Fry A Can we eliminate trachoma? 2001 Br J Ophthalmol pmid:11264123
Fuchs PC et al. Influence of variations in test methods on susceptibility of Haemophilus influenzae to ampicillin, azithromycin, clarithromycin, and telithromycin. 2001 J. Clin. Microbiol. pmid:11136745
Citterio F et al. Azithromycin treatment of gingival hyperplasia in kidney transplant recipients is effective and safe. 2001 Transplant. Proc. pmid:11377476
Solomon AW et al. Pilot study of the use of community volunteers to distribute azithromycin for trachoma control in Ghana. 2001 Bull. World Health Organ. pmid:11217675
Rothstein NM et al. Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae. 2001 J. Infect. Dis. pmid:11120929
Mizen L The activity of antibiotics against Legionella pneumophila: in vitro and in vivo studies. 2001 J. Antimicrob. Chemother. pmid:11222573
Bermudez LE et al. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium. 2001 Antimicrob. Agents Chemother. pmid:11120969
Amsden GW and Gray CL Serum and WBC pharmacokinetics of 1500 mg of azithromycin when given either as a single dose or over a 3 day period in healthy volunteers. 2001 J. Antimicrob. Chemother. pmid:11152432
Giacometti A et al. Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture. 2001 J. Antimicrob. Chemother. pmid:11152438
Gieffers J et al. Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. 2001 Circulation pmid:11157684
Weiss LM et al. The treatment of babesiosis. 2001 N. Engl. J. Med. pmid:11236789
Ranque S The treatment of babesiosis. 2001 N. Engl. J. Med. pmid:11236790
Dagan R et al. Antibiotic treatment in acute Otitis Media promotes superinfection with resistant Streptococcus pneumoniae carried before initiation of treatment. 2001 J. Infect. Dis. pmid:11237804
Hyde TB et al. Azithromycin prophylaxis during a hospital outbreak of Mycoplasma pneumoniae pneumonia. 2001 J. Infect. Dis. pmid:11237807
Simsir A et al. Rhodococcus equi and cytomegalovirus pneumonia in a renal transplant patient: diagnosis by fine-needle aspiration biopsy. 2001 Diagn. Cytopathol. pmid:11169894
Nagai K et al. Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes. 2001 Antimicrob. Agents Chemother. pmid:11600391
Cascaval RI and Lancaster DJ Hypersensitivity syndrome associated with azithromycin. 2001 Am. J. Med. pmid:11247598
Amábile-Cuevas CF et al. Comparative in vitro activity of moxifloxacin by E-test against Streptococcus pyogenes. 2001 Clin. Infect. Dis. pmid:11249826
De Diego JI et al. Comparison of amoxicillin and azithromycin in the prevention of recurrent acute otitis media. 2001 Int. J. Pediatr. Otorhinolaryngol. pmid:11249979
Intrauterine devices: antibiotic prophylaxis not necessary during insertion. 2001 Prescrire Int pmid:11718174
Golledge CL and Riley TV The efficacy of an antibiotic protocol for community-acquired pneumonia. 2001 Med. J. Aust. pmid:11700844
Toro C et al. [Prevalence of primary Helicobacter pylori resistance to eight antimicrobial agents in a hospital in Madrid]. 2001 Rev Esp Quimioter pmid:11704771
Tajima T et al. [Discussions on PRSP and BLNAR]. 2001 Jpn J Antibiot pmid:12638161
Samarendra P et al. QT prolongation associated with azithromycin/amiodarone combination. 2001 Pacing Clin Electrophysiol pmid:11707055
Hand WL and Hand DL Characteristics and mechanisms of azithromycin accumulation and efflux in human polymorphonuclear leukocytes. 2001 Int. J. Antimicrob. Agents pmid:11711255
Treadway G and Reisman A Tolerability of 3-day, once-daily azithromycin suspension versus standard treatments for community-acquired paediatric infectious diseases. 2001 Int. J. Antimicrob. Agents pmid:11711256
Page RL et al. Possible interaction between intravenous azithromycin and oral cyclosporine. 2001 Pharmacotherapy pmid:11714218
Amsden GW Advanced-generation macrolides: tissue-directed antibiotics. 2001 Int. J. Antimicrob. Agents pmid:11574189
Malizia T et al. Interaction between piroxicam and azithromycin during distribution to human periodontal tissues. 2001 J. Periodontol. pmid:11577945
Salopek-Rabatić J Chlamydial conjunctivitis in contact lens wearers: successful treatment with single dose azithromycin. 2001 CLAO J pmid:11725983
Butler T Effect of increased inoculum of Salmonella typhi on MIC of azithromycin and resultant growth characteristics. 2001 J. Antimicrob. Chemother. pmid:11733476
Joloba ML et al. Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media. 2001 Clin. Infect. Dis. pmid:11588694
Kaiser L et al. Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis. 2001 Eur. J. Clin. Microbiol. Infect. Dis. pmid:11561799
Gray GC et al. Randomized, placebo-controlled clinical trial of oral azithromycin prophylaxis against respiratory infections in a high-risk, young adult population. 2001 Clin. Infect. Dis. pmid:11528569
Urbano F and Urbano P Azithromycin in healthy adults? 2001 Clin. Microbiol. Infect. pmid:11531993
Miyazaki S et al. Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice. 2001 J. Antimicrob. Chemother. pmid:11533011
Milkovic-Kraus S and Kanceljak-Macan B Occupational airborne allergic contact dermatitis from azithromycin. 2001 Contact Derm. pmid:11553158
Gray GC and Ryan MA Azithromycin chemoprophylaxis. 2001 J. Infect. Dis. pmid:11494171
Arellano-Rodrigo E et al. [Torsade de pointes and cardiorespiratory arrest induced by azithromycin in a patient with congenital long QT syndrome]. 2001 Med Clin (Barc) pmid:11459586
Dillon JA et al. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from three Caribbean countries: Trinidad, Guyana, and St. Vincent. 2001 Sex Transm Dis pmid:11518867
Dillon JA et al. Reduced susceptibility to azithromycin and high percentages of penicillin and tetracycline resistance in Neisseria gonorrhoeae isolates from Manaus, Brazil, 1998. 2001 Sex Transm Dis pmid:11518869
Skerk V et al. Azithromycin and doxycycline in the treatment of female patients with acute urethral syndrome caused by Ureaplasma urealyticum: significance of duration of clinical symptoms. 2001 Drugs Exp Clin Res pmid:11822223
[Antibiotics in respiratory tract infections. Enormous differences in compliance]. 2001 MMW Fortschr Med pmid:11824169
[Chronic bronchitis. When to use antibiotics?]. 2001 MMW Fortschr Med pmid:11824170
Samra Z et al. In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines. 2001 Diagn. Microbiol. Infect. Dis. pmid:11337185
Calvo A et al. [Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae]. 2001 Rev Esp Quimioter pmid:11856980
Martinez SM et al. Azithromycin prophylaxis during a hospitalwide outbreak of a pertussis-like illness. 2001 Infect Control Hosp Epidemiol pmid:11876458
Kacmar J et al. A randomized trial of azithromycin versus amoxicillin for the treatment of Chlamydia trachomatis in pregnancy. 2001 Infect Dis Obstet Gynecol pmid:11916175
Chodorowska M et al. [Susceptibility to macrolide antibiotics of Bordetella pertussis and Bordetella parapertussis strains isolated from whooping cough patients in 1968 and in 1997-99]. 2001 Med Dosw Mikrobiol pmid:11757403
Jacks S et al. Pharmacokinetics of azithromycin and concentration in body fluids and bronchoalveolar cells in foals. 2001 Am. J. Vet. Res. pmid:11763173
Bragina EY et al. Electron microscopic evidence of persistent chlamydial infection following treatment. 2001 J Eur Acad Dermatol Venereol pmid:11763379
Swanston WH et al. Single dose (direct observed) azithromycin therapy for Neisseria gonorrhoeae and Chlamydia trachomatis in STD clinic attenders with genital discharge in Trinidad and Tobago. 2001 West Indian Med J pmid:11769023
Mendes CM et al. In vitro susceptibility of gram-positive cocci isolated from skin and respiratory tract to azithromycin and twelve other antimicrobial agents. 2001 Braz J Infect Dis pmid:11779453
Najib NM et al. Bioequivalence assessment of Azomycin (Julphar, UAE) as compared to Zithromax (Pfizer, USA)--two brands of azithromycin--in healthy human volunteers. 2001 Biopharm Drug Dispos pmid:11745903
Skerk V et al. Azithromycin in the treatment of chronic prostatitis caused by Chlamydia trachomatis. 2001 J Chemother pmid:11806631
Stiefelhagen P [Treatment refractory fever... und then also the kidneys fail]. 2001 MMW Fortschr Med pmid:11808449
Andersen SE et al. [Failed azithromycin treatment of Chlamydia trachomatis infection]. 2001 Ugeskr. Laeg. pmid:11810790
Zarantonelli L et al. Decreased susceptibility to azithromycin and erythromycin mediated by a novel mtr(R) promoter mutation in Neisseria gonorrhoeae. 2001 J. Antimicrob. Chemother. pmid:11328778
Safak MA et al. A comparative study of azithromycin and pseudoephedrine hydrochloride for otitis media with effusion in children. 2001 Acta Otolaryngol. pmid:11813896
Kastner U and Guggenbichler JP Influence of macrolide antibiotics on promotion of resistance in the oral flora of children. 2001 Infection pmid:11688901
Treadway G Azithromycin: a new 15-membered macrolide. 2001 Jpn J Antibiot pmid:11296412
Hafner R et al. Tolerance and pharmacokinetic interactions of rifabutin and azithromycin. 2001 Antimicrob. Agents Chemother. pmid:11302832
Stein GE and Schooley S Comparative serum bactericidal activity of clarithromycin and azithromycin against macrolide-sensitive and resistant strains of Streptococcus pneumoniae. 2001 Diagn. Microbiol. Infect. Dis. pmid:11337186
Griffith DE et al. Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease. 2001 Clin. Infect. Dis. pmid:11340525
Tan JS et al. Persistently positive culture results in a patient with community-acquired pneumonia due to Legionella pneumophila. 2001 Clin. Infect. Dis. pmid:11340527
Westfall DS et al. Inoculation of two genotypes of Hemobartonella felis (California and Ohio variants) to induce infection in cats and the response to treatment with azithromycin. 2001 Am. J. Vet. Res. pmid:11341386
Bowden FJ et al. Azithromycin and pelvic inflammatory disease in the Northern Territory. 2001 Med. J. Aust. pmid:11346115
Jacobson JM et al. Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDS. 2001 AIDS pmid:11316995
Kays MB and Denys GA In vitro activity and pharmacodynamics of azithromycin and clarithromycin against Streptococcus pneumoniae based on serum and intrapulmonary pharmacokinetics. 2001 Clin Ther pmid:11318076
Dinos GP et al. Insights into the mechanism of azithromycin interaction with an Escherichia coli functional ribosomal complex. 2001 Mol. Pharmacol. pmid:11353804
Gupta S et al. Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study. 2001 Clin Ther pmid:11318079
Parsad D et al. Azithromycin monthly pulse vs daily doxycycline in the treatment of acne vulgaris. 2001 J. Dermatol. pmid:11280457
Waring AL et al. Development of a genomics-based PCR assay for detection of Mycoplasma pneumoniae in a large outbreak in New York State. 2001 J. Clin. Microbiol. pmid:11283060
Lechner A and Bruckner DA Oligella ureolytica in blood culture: contaminant or infection? 2001 Eur. J. Clin. Microbiol. Infect. Dis. pmid:11305472
Dreses-Werringloer U et al. Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro. 2001 Antimicrob. Agents Chemother. pmid:11600348
Littler WA Clindamycin suspension and endocarditis prophylaxis. 2001 Br Dent J pmid:11352383
Ikegaya S et al. [Effect of azithromycin on cytokine production by THP-1 cells]. 2001 Jpn J Antibiot pmid:12575425
Tateda K et al. Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. 2001 Antimicrob. Agents Chemother. pmid:11353657
Kato T et al. [Effect of azithromycin on cytokine production in human bronchial epithelial cell line, BEAS-2B]. 2001 Jpn J Antibiot pmid:12575426
Pechère JC Azithromycin reduces the production of virulence factors in Pseudomonas aeruginosa by inhibiting quorum sensing. 2001 Jpn J Antibiot pmid:12575427
Tateda K et al. [MIC, sub-MIC of macrolide resistant bacteria--special reference to their quorum-sensing system]. 2001 Jpn J Antibiot pmid:12575433
Grand A et al. [Subacute infectious endocarditis due to the agent of cat scratch fever: Bartonella henselae]. 2001 Arch Mal Coeur Vaiss pmid:11265556